SVC Stent Re-Occlusion — SCE Palliative Medicine MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — In-stent thrombosis or tumour ingrowth causing recurrent luminal obstruction
Recurrent malignant SVCO after an initially effective stent should prompt imaging and interventional reassessment. Recognised mechanisms include in-stent thrombosis, tumour ingrowth or overgrowth, and less commonly migration. Anticoagulation is not automatically indicated without defining thrombosis and bleeding risk, so management was removed from the keyed diagnosis.
Reference: NICE HTG50: Stent placement for vena caval obstruction. https://www.nice.org.uk/guidance/htg50/resources/stent-placement-for-vena-caval-obstruction-pdf-50266559988421 BMJ review: Endovascular stenting for superior vena cava obstruction. https://pmc.ncbi.nlm.nih.gov/articles/PMC2432169/